CNC vs STRO
Centene Corp (CNC) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Centene Corp (CNC) is a healthcare plans company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported CNC revenue for 2024-12-31 was $163.07B. Net income was $3.29B. Revenue was up 5.9% from 2023-12-31 to 2024-12-31. CNC currently screens at market cap $28.19B and trailing P/E 8.4.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
CNC currently screens at market cap $28.19B and trailing P/E 8.4. STRO currently screens at market cap $470.8M.
Not investment advice. Open the CNC and STRO stock pages for the full models.
Not investment advice.